Seeing Is Believing

Currently out of the existing stock ratings of Do Kim, 241 are a BUY (82.53%), 51 are a HOLD (17.47%).
Analyst Do Kim, carries an average stock price target met ratio of 56.04% that have a potential upside of 35.86% achieved within 328 days. Previously, Do Kim worked at PIPER SANDLER, BMO, NOMURA.
Do Kim’s has documented 585 price targets and ratings displayed on 29 stocks. The coverage was on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on CDXS, Codexis at 15-Aug-2024.
Analyst best performing recommendations are on AKCA (AKCEA THERAPEUTICS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 11/7/2016. The price target of $48 was fulfilled within 8 days with a profit of $15.88 (49.44%) receiving and performance score of 61.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Sep-2026
$13
$1.2 (10.17%)
$24
29 days ago
(24-Sep-2026)
1/3 (33.33%)
$0.35 (2.77%)
4
Buy Since 05-Jan-2021
$9
$-2.8 (-23.73%)
$8
2 months 17 days ago
(06-Aug-2026)
5/9 (55.56%)
$2.47 (37.83%)
312
Buy Since 05-May-2026
$12
$0.2 (1.69%)
$11
2 months 17 days ago
(06-Aug-2026)
3/3 (100%)
$5.47 (83.77%)
53
Hold Since 05-Nov-2024
$11
$-0.8 (-6.78%)
3 months 16 days ago
(07-Jul-2026)
2/4 (50%)
$3.31 (43.04%)
561
Buy Since 16-May-2025
$12
$0.2 (1.69%)
$10
5 months 1 days ago
(22-May-2026)
5/5 (100%)
$6.8 (130.77%)
275